CompletedNot Applicable

Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy

France51 participantsStarted 2015-03-15

Plain-language summary

This study aims at describing survival rates over time (Kaplan-Meier estimator) in patients suffering from AIDS-related primary central nervous system lymphoma who were diagnosed from 1996 to 2014 and treated with infusions of high-dose methotrexate and combined antiretroviral therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HIV infection * AIDS-related primary central nervous system lymphoma * treated with at least one infusion of methotrexate and combine antiretroviral therapy Exclusion Criteria: * prior non-Hodgkin lymphoma

What they're measuring

Median duration of survival after diagnosis of lymphoma (years)

Timeframe: At the time of systematic files review (jan 2014) - average follow-up 7 years

Trial details

NCT IDNCT03690895

SponsorFondation Ophtalmologique Adolphe de Rothschild

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2016-10-01

View on ClinicalTrials.gov More Central Nervous System Lymphoma trials